120 related articles for article (PubMed ID: 21714071)
21. Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.
Geng Y; Shi GH; Jiang Y; Xu LX; Hu XY; Shao YQ
J Zhejiang Univ Sci B; 2005 Jan; 6(1):22-7. PubMed ID: 15593387
[TBL] [Abstract][Full Text] [Related]
22. Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.
Fei QZ; Cao L; Xiao Q; Zhang T; Zheng L; Wang XJ; Wang G; Zhou HY; Wang Y; Chen SD
Neurosci Lett; 2010 May; 475(2):61-3. PubMed ID: 20227461
[TBL] [Abstract][Full Text] [Related]
23. Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake.
De La Hera DP; Corradi GR; Adamo HP; De Tezanos Pinto F
Biochem J; 2013 Feb; 450(1):47-53. PubMed ID: 23205587
[TBL] [Abstract][Full Text] [Related]
24. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F
Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336
[TBL] [Abstract][Full Text] [Related]
25. Parkinson disease related ATP13A2 evolved early in animal evolution.
Sørensen DM; Holemans T; van Veen S; Martin S; Arslan T; Haagendahl IW; Holen HW; Hamouda NN; Eggermont J; Palmgren M; Vangheluwe P
PLoS One; 2018; 13(3):e0193228. PubMed ID: 29505581
[TBL] [Abstract][Full Text] [Related]
26. Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function.
Lin CH; Wu YR; Chen WL; Wang HC; Lee CM; Lee-Chen GJ; Chen CM
Parkinsonism Relat Disord; 2014 Jun; 20(6):600-3. PubMed ID: 24661466
[TBL] [Abstract][Full Text] [Related]
27. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove.
Dehay B; Martinez-Vicente M; Ramirez A; Perier C; Klein C; Vila M; Bezard E
Autophagy; 2012 Sep; 8(9):1389-91. PubMed ID: 22885599
[TBL] [Abstract][Full Text] [Related]
28. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
Park JS; Sue CM
Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
[TBL] [Abstract][Full Text] [Related]
29. FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.
Chen CM; Chen IC; Huang YC; Juan HF; Chen YL; Chen YC; Lin CH; Lee LC; Lee CM; Lee-Chen GJ; Lai YJ; Wu YR
PLoS One; 2014; 9(7):e101392. PubMed ID: 25029497
[TBL] [Abstract][Full Text] [Related]
30. Identification of p.Gln858* in ATP13A2 in two EOPD patients and presentation of their clinical features.
Malakouti-Nejad M; Shahidi GA; Rohani M; Shojaee SM; Hashemi M; Klotzle B; Fan JB; Elahi E
Neurosci Lett; 2014 Aug; 577():106-11. PubMed ID: 24949580
[TBL] [Abstract][Full Text] [Related]
31. Novel and reported variants in Parkinson's disease genes confer high disease burden among Indians.
Kumar S; Yadav N; Pandey S; Muthane UB; Govindappa ST; Abbas MM; Behari M; Thelma BK
Parkinsonism Relat Disord; 2020 Sep; 78():46-52. PubMed ID: 32707456
[TBL] [Abstract][Full Text] [Related]
32. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
[TBL] [Abstract][Full Text] [Related]
33. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of Parkin in early onset Parkinson's disease (PD): Novel intron 9 g > a single nucleotide polymorphism and risk of Taiwanese PD.
Wu YR; Wu CH; Chao CY; Kuan CC; Zhang WL; Wang CK; Chang CY; Chang YC; Lee-Chen GJ; Chen CM
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):229-34. PubMed ID: 19475582
[TBL] [Abstract][Full Text] [Related]
35. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of the ATP13A2 gene in patients with PD and MSA from Italy.
Gagliardi M; Procopio R; Nicoletti G; Morelli M; Brighina L; Quattrone A; Bonapace G; Malanga D; Quattrone A; Annesi G
J Neurol Sci; 2021 Nov; 430():120031. PubMed ID: 34695705
[No Abstract] [Full Text] [Related]
38. ATP13A2 G2236A variant is rare in patients with early-onset Parkinson's disease and familial Parkinson's disease from Mainland China.
Mao XY; Burgunder JM; Zhang ZJ; Chang XL; Peng R; Burgunder JM; Yang Y; Wang YC; Li T; Zhang ZJ
Parkinsonism Relat Disord; 2010 Mar; 16(3):235-6. PubMed ID: 20036179
[No Abstract] [Full Text] [Related]
39. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion.
Wang R; Tan J; Chen T; Han H; Tian R; Tan Y; Wu Y; Cui J; Chen F; Li J; Lv L; Guan X; Shang S; Lu J; Zhang Z
J Cell Biol; 2019 Jan; 218(1):267-284. PubMed ID: 30538141
[TBL] [Abstract][Full Text] [Related]
40. Novel ATP13A2 and PINK1 variants identified in Chinese patients with Parkinson's disease by whole-exome sequencing.
Chen H; Jin YH; Xue YY; Chen YL; Chen YJ; Tao QQ; Wu ZY
Neurosci Lett; 2020 Aug; 733():135075. PubMed ID: 32446772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
